Cepton, Inc. Reports First Quarter 2024 Results

Actual results, performance or achievements may, and are likely to, differ materially, and potentially adversely, from any projections and forward-looking statements and the assumptions on which those forward-looking statements were based. There can be no assurance that the data contained herein is reflective of future performance to any degree. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance as projected financial information and other information are based on estimates and assumptions that are inherently subject to various significant risks, uncertainties and other factors, many of which are beyond Cepton’s control.

Non-GAAP Financial Measures

Some of the financial information and data contained in this press release, such as non-GAAP net loss and adjusted EBITDA, have not been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). Non-GAAP net loss is defined as GAAP net (loss) income excluding stock-based compensation, realizable gain from series production award cancellation loss recovery, non-recurring transaction expenses, gain or loss on changes in fair value of earnout liability and warrants, loss on extinguishment of debt, and foreign currency transaction loss, net. As a result of the cancellation of the GM series production award in December 2023, Cepton submitted a project investment cost recovery claim and realized a gain from project cancellation cost recovery in the first quarter of 2024. This gain is excluded from the calculation of Non-GAAP net loss. Adjusted EBITDA is defined as non-GAAP net loss before interest income or expense, provision for income taxes, and depreciation and amortization.

Cepton believes these non-GAAP financial measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Cepton’s financial condition and results of operations. Cepton believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating actual and projected operating results and trends in comparing Cepton’s financial measures with other similar companies, many of which present similar non-GAAP financial measures to investors. Cepton also believes that adjusted EBITDA is useful to investors and analysts in assessing our operating performance during the periods these charges were incurred on a consistent basis with the periods during which these charges were not incurred. Our presentation of adjusted EBITDA should not be considered as an inference that our future results and financial position will be unaffected by unusual items. Cepton does not consider these non-GAAP financial measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and other amounts that are required by GAAP to be recorded in Cepton’s financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgments by management about which expenses and other amounts are excluded or included in determining these non-GAAP financial measures.

CEPTON, INC. AND SUBSIDIARIES

Reconciliation of GAAP Net Loss to Non-GAAP Net Loss and Non-GAAP Adjusted EBITDA

(In thousands, except share and per share data)

(unaudited)

 

 

Three Months Ended
March 31,

 

 

2024

 

 

 

2023

 

Net loss

$

(6,833

)

 

$

(14,742

)

Stock-based compensation

 

926

 

 

 

2,289

 

Gain from project cancellation cost recovery

 

(4,000

)

 

 

 

Non-recurring transaction expenses

 

1,560

 

 

 

 

Gain on change in fair value of earnout liability

 

 

 

 

(762

)

(Loss) gain on change in fair value of warrant liability

 

7

 

 

 

(94

)

Loss on extinguishment of debt

 

 

 

 

1,123

 

Foreign currency transaction loss, net

 

1

 

 

 

750

 

Non-GAAP net loss

$

(8,339

)

 

$

(11,436

)

Interest income, net

 

(654

)

 

 

(299

)

Provision for income taxes

 

7

 

 

 

 

Depreciation and amortization

 

103

 

 

 

110

 

Adjusted EBITDA

$

(8,883

)

 

$

(11,625

)

 

 

 

 

GAAP net loss per share attributable to common stockholders:

 

 

 

Basic

$

(0.43

)

 

$

(0.94

)

Diluted

$

(0.43

)

 

$

(0.94

)

Non-GAAP net loss per share attributable to common stockholders:

 

 

 

Basic

$

(0.52

)

 

$

(0.73

)

Diluted

$

(0.52

)

 

$

(0.73

)

Shares used in computing GAAP net loss per share attributable to common stockholders:

 

 

 

Basic

 

15,888,267

 

 

 

15,677,956

 

Diluted

 

15,888,267

 

 

 

15,677,956

 

Shares used in computing Non-GAAP net loss per share attributable to common stockholders:

 

 

 

Basic

 

15,888,267

 

 

 

15,677,956

 

Diluted

 

15,888,267

 

 

 

15,677,956

 

 

CEPTON, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(In thousands, except share data)

(unaudited)

 

 

March 31,
2024

 

December 31,
2023

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

49,218

 

 

$

50,406

 

Short-term investments

 

 

 

 

5,969

 

Accounts receivable, net of allowance for credit losses of $0 and $0, respectively

 

5,078

 

 

 

3,625

 

Inventories

 

1,861

 

 

 

2,396

 

Prepaid expenses and other current assets

 

2,236

 

 

 

1,253

 

Total current assets

 

58,393

 

 

 

63,649

 

Property and equipment, net

 

1,346

 

 

 

1,450

 

Restricted cash

 

1,283

 

 

 

1,283

 

Other assets

 

9,614

 

 

 

10,067

 

Total assets

$

70,636

 

 

$

76,449

 

LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

1,668

 

 

$

1,128

 

Operating lease liabilities, current

 

1,953

 

 

 

1,875

 

Accrued expenses and other current liabilities

 

4,136

 

 

 

4,066

 

Total current liabilities

 

7,757

 

 

 

7,069

 

Warrant liability

 

50

 

 

 

43

 

Earnout liability

 

93

 

 

 

93

 

Operating lease liabilities, non-current

 

8,186

 

 

 

8,720

 

Total liabilities

 

16,086

 

 

 

15,925

 

Commitments and contingencies (Note 17)

 

 

 

Convertible preferred stock:

 

 

 

Convertible preferred stock – Par value $0.00001 per share – 5,000,000 shares authorized at March 31, 2024 and December 31, 2023; 100,000 shares issued and outstanding at March 31, 2024 and December 31, 2023 (aggregate liquidation preference of $105.2 million and $104.1 million at March 31, 2024 and December 31, 2023)

 

98,891

 

 

 

98,891

 

Stockholders’ equity (deficit):

 

 

 

Common stock – Par value $0.00001 per share – 35,000,000 shares authorized at March 31, 2024 and December 31, 2023; 15,920,917 and 15,861,494 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively

 

 

 

 

 

Additional paid-in capital

 

97,446

 

 

 

96,583

 

Accumulated other comprehensive loss

 

(349

)

 

 

(345

)

Accumulated deficit

 

(141,438

)

 

 

(134,605

)

Total stockholders’ equity (deficit)

 

(44,341

)

 

 

(38,367

)

Total liabilities, convertible preferred stock and stockholders' equity (deficit)

$

70,636

 

 

$

76,449

 

 

CEPTON, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(In thousands, except share and per share data)

(unaudited)

 

 

Three Months Ended
March 31,

 

 

2024

 

 

 

2023

 

Lidar sensor and prototype revenue

$

1,141

 

 

$

1,240

 

Development revenue

 

805

 

 

 

245

 

Total revenue

$

1,946

 

 

$

1,485

 

 

 

 

 

Lidar sensor and prototype cost of revenue

 

1,211

 

 

 

1,448

 

Development cost of revenue

 

311

 

 

 

111

 

Total cost of revenue

 

1,522

 

 

 

1,559

 

Gross profit (loss)

 

424

 

 

 

(74

)

 

 

 

 

Operating expenses:

 

 

 

Research and development

 

5,654

 

 

 

7,238

 

Selling, general and administrative

 

6,264

 

 

 

6,731

 

Total operating expenses

 

11,918

 

 

 

13,969

 

Operating loss

 

(11,494

)

 

 

(14,043

)

Other income (expense):

 

 

 

Gain on change in fair value of earnout liability

 

 

 

 

762

 

(Loss) gain on change in fair value of warrant liability

 

(7

)

 

 

94

 

Foreign currency transaction loss, net

 

(1

)

 

 

(750

)

Loss on extinguishment of debt

 

 

 

 

(1,123

)

Other income, net

 

4,022

 

 

 

19

 

Interest income, net

 

654

 

 

 

299

 

Loss before income taxes

 

(6,826

)

 

 

(14,742

)

Provision for income taxes

 

(7

)

 

 

 

 

 

 

 

Net loss

$

(6,833

)

 

$

(14,742

)

 

 

 

 

Net loss per share, basic

$

(0.43

)

 

$

(0.94

)

Net loss per share, diluted

$

(0.43

)

 

$

(0.94

)

Weighted-average common shares, basic

 

15,888,267

 

 

 

15,677,956

 

Weighted-average common shares, diluted

 

15,888,267

 

 

 

15,677,956

 

 

CEPTON, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(In thousands)

(unaudited)

 

 

Three Months Ended
March 31,

 

 

2024

 

 

 

2023

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

Net loss

$

(6,833

)

 

$

(14,742

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

Depreciation and amortization

 

103

 

 

 

110

 

Stock-based compensation

 

926

 

 

 

2,289

 

Amortization of right-of-use asset

 

416

 

 

 

382

 

Amortization (accretion), other

 

(25

)

 

 

107

 

Gain on change in fair value of earnout liability

 

 

 

 

(762

)

Loss (gain) on change in fair value of warrant liability

 

7

 

 

 

(94

)

Foreign currency transaction loss, net

 

1

 

 

 

750

 

Loss from extinguishment of debt

 

 

 

 

1,123

 

Changes in operating assets and liabilities:

 

 

 

Accounts receivable, net

 

(1,453

)

 

 

260

 

Inventories

 

534

 

 

 

(453

)

Prepaid expenses and other current assets

 

(983

)

 

 

513

 

Other long-term assets

 

37

 

 

 

181

 

Accounts payable

 

541

 

 

 

(680

)

Accrued expenses and other current liabilities

 

71

 

 

 

502

 

Operating lease liabilities

 

(457

)

 

 

89

 

Net cash used in operating activities

 

(7,115

)

 

 

(10,425

)

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

Purchases of property and equipment

 

 

 

 

(556

)

Purchases of short-term investments

 

 

 

 

(37,806

)

Proceeds from maturities of short-term investments

 

6,000

 

 

 

3,700

 

Net cash provided by (used in) investing activities

 

6,000

 

 

 

(34,662

)

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

Proceeds from convertible preferred stock, net of transaction costs

 

 

 

 

99,884

 

Repayment of Koito secured term loan

 

 

 

 

(45,220

)

Payments of employee taxes related to vested restricted stock units

 

(63

)

 

 

 

Proceeds from issuance of common stock options

 

 

 

 

8

 

Net cash (used in) provided by financing activities

 

(63

)

 

 

54,672

 

 

 

 

 

Effect of exchange rate changes on cash

 

(10

)

 

 

434

 

 

 

 

 

Net (decrease) increase in cash, cash equivalents and restricted cash

 

(1,188

)

 

 

10,019

 

Cash, cash equivalents and restricted cash, beginning of period

 

51,689

 

 

 

34,518

 

Cash, cash equivalents and restricted cash, end of period

$

50,501

 

 

$

44,537

 





© 2024 Internet Business Systems, Inc.
670 Aberdeen Way, Milpitas, CA 95035
+1 (408) 882-6554 — Contact Us
ShareCG™ is a trademark of Internet Business Systems, Inc.

Report a Bug Report Abuse Make a Suggestion About Privacy Policy Contact Us User Agreement Advertise